Literature DB >> 23745167

Cancer Stem Cells and the Bone Marrow Microenvironment.

Yusuke Shiozawa1, Russell S Taichman.   

Abstract

"Cancer" is a disease that can spread to the other organs over time. The prognosis of cancer patients with metastasis is generally poor. Accordingly, there is an urgent need to establish a greater understanding of metastatic processes. It is highly likely that cancer stem cells (CSCs) are the key cells that mediate metastases, even while the cellular origin of CSCs remains unknown. Growing evidence has also revealed that the microenvironment has profound effects on the regulation of CSCs. Recently, it has been shown that bone metastatic cancer cells target the microenvironment or 'niche' which houses hematopoietic stem cells (HSCs). The major function of the HSC niche is to maintain 'stemness' of HSCs. These findings suggest that by targeting the HSC niche metastatic cells parasitize the very foundation of hematopoiesis to maintain their stemness. These observations suggest that there will be a need to target the HSC niche to provide effective therapies to eradicate metastatic CSCs.

Entities:  

Keywords:  Bone marrow niche; Cancer stem cells; Disseminated tumor cells; and Tumor heterogeneity

Year:  2012        PMID: 23745167      PMCID: PMC3671623          DOI: 10.1038/bonekey.2012.48

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  47 in total

1.  Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.

Authors:  Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

2.  Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice.

Authors:  M Ninomiya; A Abe; A Katsumi; J Xu; M Ito; F Arai; T Suda; M Ito; H Kiyoi; T Kinoshita; T Naoe
Journal:  Leukemia       Date:  2006-10-12       Impact factor: 11.528

3.  Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.

Authors:  Taiki Moriyama; Kenoki Ohuchida; Kazuhiro Mizumoto; Lin Cui; Naoki Ikenaga; Norihiro Sato; Masao Tanaka
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

4.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors:  Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal:  Nat Biotechnol       Date:  2007-10-21       Impact factor: 54.908

5.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

6.  Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization.

Authors:  Halvard Bonig; Korashon L Watts; Kai-Hsin Chang; Hans-Peter Kiem; Thalia Papayannopoulou
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

7.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

9.  Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.

Authors:  Yusuke Shiozawa; Aaron M Havens; Younghun Jung; Anne M Ziegler; Elisabeth A Pedersen; Jingcheng Wang; Jianhua Wang; Ganwei Lu; G David Roodman; Robert D Loberg; Kenneth J Pienta; Russell S Taichman
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

10.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

View more
  6 in total

Review 1.  Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit.

Authors:  Natalie A Sims; T John Martin
Journal:  Bonekey Rep       Date:  2014-01-08

Review 2.  Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.

Authors:  Michaela R Reagan; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2015-11-26       Impact factor: 20.543

Review 3.  Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.

Authors:  Scott Sauer; Damon R Reed; Michael Ihnat; Robert E Hurst; David Warshawsky; Dalit Barkan
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 4.  Emerging insights into the biology of metastasis: A review article.

Authors:  Soussan Irani
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

Review 5.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14

Review 6.  Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis.

Authors:  Nicola Graham; Bin-Zhi Qian
Journal:  Int J Mol Sci       Date:  2018-04-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.